Authorities in Xuzhou, China, fined Jiangsu Nhwa Pharmaceutical (SHE:002262) 491,700 yuan for safety violations at a branch in Jiawang.
The drug company's production exceeded permitted product types and its storage facilities went beyond their permitted scopes, according to a Tuesday filing with the Shenzhen bourse.
Authorities also confirmed the drug company's compliance with correction orders.